Everything You Actually Need to Know About Bioidentical Hormone Therapy

Written by Anat Sapan, MD, board-certified OB-GYN · Published August 2024 · Updated November 2026

Bioidentical hormone therapy (BHRT) uses hormones that are molecule-for-molecule identical to the ones your ovaries made: estradiol, progesterone and, when needed, testosterone. Some are FDA-approved and available at any pharmacy; others are compounded to a custom dose. Used at the right time and in the right form, hormone therapy is the most effective treatment we have for hot flashes, night sweats and vaginal dryness, and it protects bone.[1] This guide covers what bioidentical actually means, how FDA-approved and compounded options differ, what the research shows on safety, and who it helps.

What Does "Bioidentical" Actually Mean?

A hormone is bioidentical when its chemical structure is exactly the same as the hormone your body makes. That is the whole definition. The ones I use most:

• Estradiol (E2): your main premenopausal estrogen
• Estriol (E3): a weaker estrogen, often blended with estradiol
• Progesterone: the hormone your ovaries make after ovulation
• Testosterone: yes, a women's hormone too, and one that declines steadily with age
• DHEA: an adrenal precursor your body converts into other hormones

Compare that with older conventional therapy: conjugated equine estrogens, made from pregnant horse urine, and synthetic progestins such as medroxyprogesterone acetate. Those were the drugs tested in the Women's Health Initiative, and they are not the same molecules.

One myth to clear up: "bioidentical" does not mean "natural" or "plant-based" in any special sense. Both FDA-approved and compounded bioidentical hormones are made in a lab from plant sterols. What matters is the final molecule, the dose and how it is delivered.

FDA-Approved Bioidentical Hormones You Can Get Today

Many women do not realize their regular pharmacy already carries bioidentical hormones:

• Estradiol as a patch, gel, spray, vaginal ring, vaginal cream or tablet
• Oral micronized progesterone (Prometrium and generics)
• Vaginal DHEA (prasterone) for vaginal dryness and painful sex

What the FDA-approved list does not include: any testosterone product designed for women in the United States, estriol, or combined estradiol and estriol blends. Those are only available through compounding. I wrote separately about what testosterone does for women and why one estrogen is never enough.

Compounded Versus FDA-Approved: What Is The Difference?

Compounded hormones are prepared by a licensed pharmacy to a specific prescription. Pharmacies doing this for individual patients are regulated by state boards of pharmacy and under section 503A of federal law, and they must use FDA-registered active ingredients.

Why I prefer compounded hormones for many of my patients:

• Custom doses. Standard products come in fixed strengths. Not every woman fits them.
• Combinations not sold commercially, such as estradiol with estriol, or testosterone at a woman's dose.
• Fewer additives. In my practice, hormones are compounded in organic jojoba oil with nothing else added, avoiding the fillers, dyes, peanut oil and other excipients some commercial products contain.
• Delivery through the skin, which avoids the first pass through the liver.

Why compounded is not a lesser choice. A hormone your body makes cannot be patented. Only a delivery system can, which is why commercial products are built around patented patches, gels and capsules, and why there is little financial incentive to study custom doses. FDA testing is enormously expensive, so not every formulation can go through it. FDA approval is also not the whole story: many FDA-approved medications are prescribed off-label every day, and many carry significant side effects. Compounded bioidentical hormones have decades of clinical experience behind them.

What is actually in some commercial hormones. Read the inactive ingredient lists on the FDA labels and you find things most women would never choose to take every day:

• Prometrium (oral progesterone): peanut oil in every capsule, plus FD&C Red No. 40 and D&C Yellow No. 10 in the 100 mg, and D&C Yellow No. 10 and FD&C Yellow No. 6 in the 200 mg (FDA label, 2026)
• Estrace tablets (oral estradiol): lactose and corn starch, plus FD&C Blue No. 1 with D&C Red No. 27 in the 1 mg, and FD&C Blue No. 1 with FD&C Yellow No. 5 (tartrazine) in the 2 mg
• Premarin tablets: estrogens purified from pregnant mares' urine, with lactose, sucrose and different synthetic dyes in every strength (Pfizer label)
• Bijuva capsules and Imvexxy vaginal inserts: FD&C Red No. 40, propylene glycol and soy lecithin
• Patches and gels: for example, Minivelle's patch contains dipropylene glycol and acrylic and silicone adhesives, and Divigel contains alcohol and propylene glycol

My approach: that is why I choose what I choose: bioidentical hormones compounded in organic jojoba oil with nothing else added, at the dose your body actually needs, adjusted based on how you feel.

Why The Molecule Matters: Progesterone Versus Progestins

This is where "bioidentical" stops being a marketing term and starts being a safety issue.

In the French E3N study of more than 80,000 women, estrogen combined with natural progesterone showed no increase in breast cancer risk (relative risk 1.00), while estrogen combined with most synthetic progestins raised it by 69%.[2] I explain the biology in progesterone is not a progestin.

The route matters too. Oral estrogen passes through the liver and raises clotting factors. In the ESTHER study, oral estrogen raised the risk of blood clots about fourfold, while estrogen through the skin did not raise it, and micronized progesterone was not linked to clots.[3] The UK Million Women Study confirmed it: no increased clot risk with transdermal estrogen.[4] This is why I almost always prescribe estrogen through the skin.

What Hormone Therapy Treats

• Hot flashes and night sweats. Hormone therapy remains the most effective treatment, and ACOG's 2026 guideline gives it a strong recommendation.[5]
• Sleep disruption from night sweats, also a strong ACOG recommendation.[5]
• Vaginal dryness, painful sex and recurrent bladder symptoms.
• Mood, anxiety, brain fog and joint aches. In my practice these often improve alongside the hot flashes. Many women have spent years being referred to orthopedists, ENT specialists and psychiatrists for symptoms that were hormonal all along, including joint and shoulder pain, ringing in the ears and new anxiety.
• Low libido and energy, where testosterone is often part of the plan.

What It Protects

Bone. In the Women's Health Initiative, hormone therapy reduced total fractures by about 24%.[6] My bone health guide covers this in more depth.

Heart, when started early. In a Danish randomized trial of women who began hormone therapy within about seven months of menopause, heart failure, heart attack and cardiac death fell by 52% over ten years, with a trend toward lower mortality and no increase in cancer.[7] Women 50 to 59 on estrogen in the WHI had less calcified plaque in their coronary arteries, with a 31% lower chance of a high calcium score and 54% lower in women who took it consistently.[8] This is the timing hypothesis: started before 60 or within ten years of menopause, hormone therapy reduces heart disease and all-cause mortality.[9] Started much later, the picture is different, which I explain in why starting estrogen after 60 is different.

Longevity. Over 18 years of follow-up, the WHI found hormone therapy did not increase deaths from any cause, heart disease or cancer, and women in their 50s fared notably better than women in their 70s.[10] One analysis estimated that between 18,000 and 91,000 American women aged 50 to 59 who had a hysterectomy died prematurely in the decade after 2002 because they avoided estrogen.[11]

What About Breast Cancer?

This is the question every woman asks, so here is the full picture.

• Estrogen alone lowered breast cancer. In the WHI, women taking estrogen alone had 22% fewer breast cancers and 40% fewer breast cancer deaths than placebo over 20 years.[12]
• The progestin was the problem. The same trial found higher risk when estrogen was combined with medroxyprogesterone acetate, a synthetic progestin.[12] With natural progesterone, the E3N study found no increase.[2]
• The counterpoint, in fairness. A large 2019 analysis of observational studies in The Lancet found a modest increase in risk with most systemic hormone types, smallest with estrogen alone and largest with estrogen plus progestin.[13]
• After breast cancer. In a review of 25 studies of hormone therapy in breast cancer survivors, only one showed a higher recurrence rate, and that trial used a synthetic progestin.[14] It is an individualized decision, which I cover in is HRT safe after breast cancer.

Why So Many Doctors Still Hesitate

In 2002, the first Women's Health Initiative results were reported as if they applied to every woman on every hormone. They did not. The average participant was 63, many were more than a decade past menopause, and they took horse-derived estrogen with a synthetic progestin. Later analyses showed younger women close to menopause had a very favorable balance of benefit and risk.[15] But prescriptions collapsed, and a generation of doctors trained with almost no menopause education.

The label has finally caught up. In November 2025, the FDA removed the boxed warnings about heart disease, breast cancer and dementia from hormone therapy. The endometrial cancer warning remains for estrogen taken without progesterone by women with a uterus.[16] And the Menopause Society no longer recommends stopping hormone therapy at an arbitrary age; the decision should be individualized.[1]

How I Personalize Bioidentical Hormone Therapy

No two women experience menopause the same way, so no two treatment plans should look the same. Every plan starts with a real conversation: your symptoms, your history, your goals. Then I start low and adjust based on how you feel, using your symptoms as the guide:

• Poor sleep, anxiety or irritability often point to progesterone.
• Persistent hot flashes or night sweats usually mean estrogen needs adjusting.
• Low motivation, libido, muscle tone or mood can signal that testosterone should be part of the conversation.

Hormone therapy is not static. Absorption through the skin varies, life changes, and your needs shift over time, so we reassess regularly. I describe what the early weeks usually feel like in your first 6 weeks on bioidentical hormone therapy.

Who Is A Good Candidate?

I believe nearly every woman can benefit from hormone therapy, with the exception of the few who truly cannot take hormones. Age or years since menopause alone does not disqualify you. Timing changes how I start, which route and dose I choose and how closely we monitor, but it does not close the door. Hormone therapy needs extra care if you have unexplained vaginal bleeding, active or recent hormone-sensitive cancer, a prior blood clot or stroke, or active liver disease. Many of these are not automatic no's; they mean the route, dose and monitoring have to be chosen carefully.

Frequently Asked Questions

Are bioidentical hormones safer than synthetic hormones? The best evidence favors natural progesterone over synthetic progestins for breast and clot safety, and transdermal estrogen over oral estrogen for clot risk. Those are differences of molecule and route, which apply whether the product is compounded or FDA-approved.

Are compounded hormones FDA-approved? No. Compounding pharmacies are regulated and use FDA-registered ingredients, but custom preparations are not individually FDA-tested, because testing every possible dose and formulation is not feasible. Keep in mind that many FDA-approved drugs are used off-label every day, and approval does not mean a product is free of side effects or additives.

Is bioidentical hormone therapy covered by insurance? FDA-approved estradiol and progesterone usually are. Compounded hormones usually are not.

How long can I stay on it? There is no arbitrary cutoff. Many women stay on hormone therapy for years with regular reassessment of benefits and risks.

Do I need hormone testing before I start? Symptoms guide treatment. Labs help rule out other causes and can help with monitoring over time, but a single estrogen or progesterone level does not decide your dose.

If you are ready to find out whether bioidentical hormone therapy is right for you, book a complimentary discovery call at doctoranat.com. No pressure, no commitment. Just a real conversation about your symptoms and your options.

Book your complimentary discovery call at doctoranat.com

Dr. Anat Sapan is a board-certified OB-GYN and menopause specialist, exclusively focused on personalized bioidentical hormone therapy for women in their 40s, 50s, 60s, and beyond. She serves patients via telemedicine in California, Florida, New York, and Illinois.

References

1. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. PubMed
2. Fournier A, et al. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-11. PubMed
3. Canonico M, et al. Hormone therapy and venous thromboembolism among postmenopausal women: the ESTHER study. Circulation. 2007;115(7):840-5. PubMed
4. Sweetland S, et al. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost. 2012;10(11):2277-86. PubMed
5. American College of Obstetricians and Gynecologists. Management of menopause-related vasomotor, sleep, and mood symptoms. Clinical Practice Guideline No. 13. Obstet Gynecol. 2026;148(5):e345-e369. Summary
6. Cauley JA, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA. 2003;290(13):1729-38. PubMed
7. Schierbeck LL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 2012;345:e6409. PubMed
8. Manson JE, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med. 2007;356(25):2591-602. PubMed
9. Hodis HN, Mack WJ. Menopausal hormone replacement therapy and reduction of all-cause mortality and cardiovascular disease: it is about time and timing. Cancer J. 2022;28(3):208-223. PubMed
10. Manson JE, et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women's Health Initiative randomized trials. JAMA. 2017;318(10):927-938. PubMed
11. Sarrel PM, et al. The mortality toll of estrogen avoidance: an analysis of excess deaths among hysterectomized women aged 50 to 59 years. Am J Public Health. 2013;103(9):1583-8. PubMed
12. Chlebowski RT, et al. Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the Women's Health Initiative randomized clinical trials. JAMA. 2020;324(4):369-380. PubMed
13. Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk. Lancet. 2019;394(10204):1159-1168. PubMed
14. Bluming AZ. Hormone replacement therapy after breast cancer: it is time. Cancer J. 2022;28(3):183-190. PubMed
15. Lobo RA. Where are we 10 years after the Women's Health Initiative? J Clin Endocrinol Metab. 2013;98(5):1771-80. PubMed
16. FDA removes boxed warning from hormone therapies for menopause. Pharmacy Times. November 10, 2025. Pharmacy Times